Interactive Session:
154. Interactive Cases in Transplant ID
Saturday, October 5, 2013: 8:30 AM-10:00 AM
Room: The Moscone Center: Esplanade Ballroom 301-310
Co-organized with the Immunocompromised Host Society

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • demonstrate an understanding of the differential diagnosis of fever in a transplant patient
  • apply the latest diagnostic approaches to evaluation of the transplant patient with infection
  • recognize new and emerging syndromes causing illness in the transplant patient

Target Audience: pharmacists, microbiologists, members-in-training, infectious diseases physicians, infectious diseases pediatricians, health care workers, fellows, clinicians, academicians

Tracks: Pediatric ID, Adult ID

Interactive Moderator:  Kenneth Pursell, MD, The University of Chicago Medicine

Presentations:

8:30 AM
Interactive Panelist
Janice Brown, MD

8:50 AM
Interactive Panelist
Cameron Wolfe, MD

9:10 AM
Interactive Panelist
Genovefa Papanicolaou, MD

9:30 AM
Interactive Panelist
Kimberly Hanson, MD, MHS

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session.

ACPE Number:

Disclosures:

K. Pursell, None

J. Brown, Cellerant Therapeutics, Inc: Scientific Advisor, Consulting fee and Licensing agreement or royalty
Merck: Clinical adjuciation committee, Investigator, multicenter trial, Consulting fee and Research support
Astellas: nvestigator, multicenter trial, Research support

C. Wolfe, Merck: Investigator, Research support
GSK: Scientific Advisor, Consulting fee

G. Papanicolaou, Chimerix, Inc: Consultant and Investigator, Consulting fee and Research support
Astellas: Investigator, Research support
Merck, Inc: Consultant and Investigator, Consulting fee and Research support
ViroPharma, Inc: Investigator, Research support
GSK: Investigator, Research support

K. Hanson, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.